Average Co-Inventor Count = 8.67
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Methylgene, Inc. (14 from 53 patents)
14 patents:
1. 9018378 - Processes and intermediates for preparing fused heterocyclic kinase inhibitors
2. 8906852 - Inhibitors of protein tyrosine kinase activity
3. 8907091 - Processes and intermediates for preparing fused heterocyclic kinase inhibitors
4. 8846927 - Inhibitors of protein tyrosine kinase activity
5. 8759522 - Inhibitors of protein tyrosine kinase activity
6. 8729268 - Inhibitors of protein tyrosine kinase activity
7. 8470850 - Inhibitors of VEGF receptor and HGF receptor signalling
8. 8455484 - Selected inhibitors of protein tyrosine kinase activity
9. 8404846 - Inhibitors of protein tyrosine kinase activity
10. 8389541 - Inhibitors of protein tyrosine kinase activity
11. 8329726 - Inhibitors of VEGF receptor and HGF receptor signaling
12. 8093264 - Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling
13. 7790729 - Inhibitors of VEGF receptor and HGF receptor signaling
14. 7772247 - Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor